Journal of Biosciences

, Volume 33, Issue 5, pp 643–651 | Cite as

Multifactorial etiology of Kaposi’s sarcoma: a hypothesis



Aluminosilicates co-carcinogenesis Kaposi’s sarcoma human herpesvirus-8 human immunodeficiency virus nitrite inhalants 

Abbreviations used




human herpesvirus — 8


human immunodeficiency virus


human T-lymphotrophic virus type 3




interleukin-1 beta


Kaposi’s sarcoma


lymphadenopathy-associated virus


Multicenter AIDS Cohort Study


Pneumocystis carinii pneumonia


tumour necrosis factor — alpha


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albini A, Barillari G, Benelli R, Gallo R C and Ensoli B 1995 Angiogenic properties of human immunodeficiency virus type 1 Tat protein; Proc. Natl. Acad. Sci. USA 92 4838–4842PubMedCrossRefGoogle Scholar
  2. Armenian H K, Hoover D R, Rubb S, Merz S, Kaslow R, Visscher B, et al 1993 Composite risk score for KS based on a case-control and longitudinal study in MACS population; Am. J. Epidemiol. 138 256–265PubMedGoogle Scholar
  3. Barre-Sinoussi F, Cherman J C, Rey F, et al 1983 Isolation of a T-lymphotropic retrovirus from a patient at risk for AIDS; Science 220 868–871PubMedCrossRefGoogle Scholar
  4. Beral V, Peterman T A, Berkelman R L and Jaffe H 1990 Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection?; Lancet 335 123–128PubMedCrossRefGoogle Scholar
  5. Bilen N, Bayramgurler D, Aydeniz B, Apaydin R and Ozkara S K 2002 Possible causal role of lisinopril in a case of Kaposi’s sarcoma (letter); Br. J. Dermatol. 147 1042–1044PubMedCrossRefGoogle Scholar
  6. Boldogh I, Beth E and Huang E S 1981 Kaposi’s sarcoma. IV. Detection of CMV DNA, CMV RNA, and CMNA in tumor biopsies; Int. J. Cancer 28 469–474PubMedCrossRefGoogle Scholar
  7. Casper C, Carroll D, Miller K G, Judson F D, Meier A S, Pauk J S, et al 2006 HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study; Sex. Transm. Infect. 82 229–135PubMedCrossRefGoogle Scholar
  8. Centers for Disease Control 1991 Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men — New York City and California; Morbid. Mort. Weekly Rep. 30 305–308Google Scholar
  9. Chang Y, Cesarman E, Pessin M S, Lee F, Culpepper J, Knowles D M, et al 1994 Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma; Science 266 1865–1869PubMedCrossRefGoogle Scholar
  10. Chang Y and Moore P S 1996 Kaposi’s sarcoma (KS)-associated herpesvirus and its role in KS; Infect. Agents Dis. 5 215–222PubMedGoogle Scholar
  11. Dal Maso L, Serraino D and Franceschi S 2001 Epidemiology of AIDS-related tumours in developed and developing countries; Eur. J. Cancer 37 1188–1201CrossRefGoogle Scholar
  12. Dax E M, Adler W H, Nagel J E, Lange W R and Jaffe J H 1991 Amyl nitrite alters human in vitro immune function; Immunopharmacol. Immunotoxicol. 13 577–587PubMedCrossRefGoogle Scholar
  13. Duker N and Rezza G 2003 Human herpesvirus 8 epidemiology: what we do and what we do not know; AIDS 17 1717–1730CrossRefGoogle Scholar
  14. Dunkel V C, Rogers-Back A M, Lawlor T E, Harbell J W and Cameron T P 1989 Mutagenicity of some alkyl nitrites used as recreational drugs; Environ. Mol. Mutagen. 14 115–122PubMedCrossRefGoogle Scholar
  15. Engels E, Sinclair M, Biggar R, et al 2002 Latent analysis of HHV-8 assay performance and infection prevalence in sub-Saharan Africa, Int. J. Cancer 88 1003–1008CrossRefGoogle Scholar
  16. Ensoli B, Gendelman R, Markham P, Fiorelli Y, Colombini S, Raffeld M, et al 1994 Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi’s sarcoma; Nature (London) 371 674–680CrossRefGoogle Scholar
  17. Friedman-Kien A E 1989 Color Atlas of AIDS (Philadelphia: WB Saunders)Google Scholar
  18. Ganem D 2006 KSHV infection and the pathogenesis of Kaposi’s sarcoma; Annu. Rev. Pathol. 1 273–296PubMedCrossRefGoogle Scholar
  19. Gallo R 1991 Virus Hunting. AIDS, Cancer and the Human Retrovirus: A story of scientific discovery (USA: A New Republic Book)Google Scholar
  20. Giraldo G, Beth E and Haguenau F 1972 Herpes-type virus particles in tissue culture of Kaposi’s sarcoma from different geographic regions; J. Natl. Cancer Inst. 49 1509–1513PubMedGoogle Scholar
  21. Giraldo G, Beth E and Huang E S 1980 Kaposi’s sarcoma and its relationship to cytomegalovirus (CMV) III CMV DNA and CMV early antigens in Kaposi’s sarcoma; Int J. Cancer 26 23–29PubMedCrossRefGoogle Scholar
  22. Giraldo G, Beth E, Henle W, et al 1978 Antibody patterns to herpesviruses in Kaposi’s sarcoma: II. Serological association of American Kaposi’s sarcoma with cytomegalovirus; Int. J. Cancer 22 126–131PubMedCrossRefGoogle Scholar
  23. Giraldo G, Beth E, Koutilsky F M, et al 1975 Antibody patterns to herpesviruses in Kaposi’s sarcoma: serological association of Europeans with cytomegalovirus; Int. J. Cancer 15 839–848PubMedCrossRefGoogle Scholar
  24. Haverkos H W 2004 Viruses, chemicals and co-carcinogenesis; Oncogene 23 6492–6499PubMedCrossRefGoogle Scholar
  25. Haverkos H W and Curran J W 1982 The current outbreak of Kaposi’s sarcoma and opportunistic infections; CA- A Cancer J. Clinicians 32 330–339CrossRefGoogle Scholar
  26. Haverkos H W, Pinsky P, Drotman D P and Bregman D 1985 Disease manifestation among homosexual men with AIDS: a possible role of nitrites in Kaposi’s sarcoma; Sex Transm. Dis. 12 203–208PubMedCrossRefGoogle Scholar
  27. Haverkos H W and Drotman D P 1995 Measuring inhalant nitrite exposure in gay men: Implications for elucidating the etiology of AIDS-related Kaposi’s sarcoma; Genetica 95 157–164PubMedCrossRefGoogle Scholar
  28. Haverkos H W, Kopstein A N, Wilson H and Drotman P 1994 Nitrite inhalants: History, epidemiology, and possible links to AIDS; Environ. Health Perspect. 10 858–861CrossRefGoogle Scholar
  29. Kaposi M 1872 Idiopathisches multiples Pigmentsarkom der Haut.; Arch. Dermatol. Syphillis 4 265–273CrossRefGoogle Scholar
  30. Kuhn T S 1962 The structure of scientific revolutions (Chicago: The University of Chicago Press) pp 144–145Google Scholar
  31. Larbre J P, Nicolas J F, Collet P, Larbre J and Llorca G 1991 Kaposi’s sarcoma in a patient with rheumatoid arthritis: possible responsibility of captropril in the development of lesioins; J. Rheumatol. 18 476–477PubMedGoogle Scholar
  32. Lin C J, Katongole-Mbidde E, Byekwaso T, Orem J, Rabkin C S and Mbulaiteye S M 2008 Intestinal parasites in Kaposi sarcoma patients in Uganda: indication of shared risk factors or etiological association; Am. J. Trop. Med. Hyg. (in press)Google Scholar
  33. Lo S-C 1986 Isolation and identification of a novel virus from patients with AIDS; Am. J. Trop. Med. Hyg.. 35 675–676PubMedGoogle Scholar
  34. Mirvish S S and Haverkos H W 1987 Butyl nitrite in the induction of KS in AIDS; N. Engl. J. Med. 317 1603PubMedGoogle Scholar
  35. Mirvish S S, Williamson J, Babcook D and Chen S-C 1993 Mutagenicity of iso-butyl nitrite vapor in the Ames test and some relevant chemical properties, including the reaction of iso-butyl nitrite with phosphate; Environ. Mol. Mutagen. 21 247–252PubMedCrossRefGoogle Scholar
  36. Moore P S and Chang Y 1995 Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and those without HIV infection; N. Engl. J. Med. 332 1181–1185PubMedCrossRefGoogle Scholar
  37. O’Brien T R, Kedes D, Ganem D, Macrae D R, Rosenberg P S, Molden J, et al 1999 Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factor, and relationship to Kaposi’s sarcoma; J. Infect. Dis. 180 1010–1017PubMedCrossRefGoogle Scholar
  38. Oettle A G 1962 Geographical and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes; Acta Union Int. Contra. Cancrum 18 330–363Google Scholar
  39. Osmond D H, Buchbinder S, Cheng A, Graves A, Vittinghoff E, Cossen C K, et al 2002 Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic; JAMA 287 221–225PubMedCrossRefGoogle Scholar
  40. Pauk J, Huang M L, Brodie S J, Wald A, Koelle D M, Schacker T, et al 2000 Mucosal shedding of human herpes virus 8 in men; N. Engl. J. Med. 343 1369–1377PubMedCrossRefGoogle Scholar
  41. Polk F, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, et al 1987 Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men; N. Engl. J. Med. 316 62–66Google Scholar
  42. Popovic M, Sarngadharan M G, Read E and Gallo R C 1984 Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS; Science 224 503–505PubMedCrossRefGoogle Scholar
  43. Puppin Jr D, Rybojad M, de la Chappelle C and Morel P 1990 Kaposi’s sarcoma associated with captopril; Lancet 336 1251–1252PubMedCrossRefGoogle Scholar
  44. Rous P 1965 Viruses and tumour causation. An appraisal of present knowledge; Nature (London) 207 457–463CrossRefGoogle Scholar
  45. Samaniego F, Markham P D, Gendelman R, Gallo R C and Ensoli B 1997 Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi’s sarcoma-like lesions in nude mice; J. Immunol. 158 1887–1894PubMedGoogle Scholar
  46. Simpson G, Schulz T F, Whitby D, et al 1996 Prevalence of KS-associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen; Lancet 346 1133–1138CrossRefGoogle Scholar
  47. Southam C M 1963 The complex etiology of cancer; Cancer Res. 23 1105–1115PubMedGoogle Scholar
  48. Straus S E 2000 Human herpesvirus type 8 (Kaposi’ssarcoma-associated herpesvirus) Chapter 130; in Principles and practice of infectious diseases Fifth edition (eds) G L Mandell, J E Bennett, R Dolin (New York: Churchill Livingstone)Google Scholar
  49. Szajerka T and Jablecki J 2007 Kaposi’s sarcoma revisited; AIDS Rev. 9 230–236PubMedGoogle Scholar
  50. Vogt B and Frey F J 1997 Inhibition of angiogenesis in Kaposi’s sarcoma by captopril; Lancet 349 1148PubMedCrossRefGoogle Scholar
  51. Whitby D, Luppi M, Barozzi P, et al 1998 Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy; J. Natl. Cancer Inst. 90 395–397PubMedCrossRefGoogle Scholar
  52. Ziegler J 1993 Endemic Kaposi’s sarcoma in Africa and local volcanic soils; Lancet 342 1348–1351PubMedCrossRefGoogle Scholar
  53. Ziegler J and Katongole-Mbidde E 1996 Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection; Int. J. Cancer 65 200–203PubMedCrossRefGoogle Scholar
  54. Ziegler J, Newton R, Bourboulia D, Casabone D, Beral V, Mbidde E, et al 2003 Risk factors for Kaposi’s sarcoma: a case-control study of HIV-seronegative people in Uganda; Int. J. Cancer 103 233–240PubMedCrossRefGoogle Scholar
  55. Ziegler J, Newton R, Katongole-Mbidde E, Mbulaitaye S, De Cock K, Wabinga H, et al 1997 Risk factors for Kaposi’s sarcoma in HIV-positive subjects in Uganda; AIDS 11 1619–1626PubMedCrossRefGoogle Scholar
  56. Ziegler J L, Simonart T and Snoeck R 2001 Kaposi’s sarcoma, oncogenic viruses, and iron; J. Clin. Virol. 20 127–130PubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2008

Authors and Affiliations

  1. 1.Captain US Public Health Service (Retired) Preventive Medicine and BiometricsUniformed Services University of the Health SciencesBethesdaUSA

Personalised recommendations